Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Twist Bioscience Corporation

Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. 

Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. 

Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise unavailable. Our technology overcomes inefficiencies and enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. We offer both the quality and quantity researchers need now to rapidly realize opportunities ahead. 

Twitter          @TwistBioscience
Facebook     facebook.com/TwistBioscience
YouTube       youtube.com/TwistBioscience

#WeMakeDNA

Capital World Investors

Kangmei Pharmaceutical

NFT Investment

Reinet Investments S.C.A.

Biomatics Capital Partners

Ditch Plains Capital Management LP

3W Partners

Bay City Capital

Dentsu Ventures

Asset Management Ventures (AMV)

E Squared Capital Management

Twist Bioscience

🧬 If you read one “look back” piece this time of year, this is certainly the one you should read. By Emily Leproust: A 10 Year Leap That Has Changed The World.

Twist Bioscience, #NGS, #DataStorage, #TwistBlog, #DNA

We have a treat for you! Aaron Sato’s talk from #ANTIBODYENG: “Writing the Future of Biologics with an Integrated Offering of Immunization, Libraries, & Machine Learning” including super interesting case studies. Check it out: https://lnkd.in/gHeGp9Ci

#antibody #antibodydiscovery #DNA #machinelearning

Don't miss this opportunity to accelerate your experiments with Twist Bioscience’s new Express Genes service! Unlock the door to limitless possibilities and propel your genetic research forward.

Order your Express Genes before capacity runs out: https://lnkd.in/gKR4i9fX

#gene #genes #DNA

Our miniaturization process allows us to write DNA more sustainably than traditional 96 well plate methods. A LOT more…

Learn more here: bit.ly/3QZzkjP

Twist Bioscience, #ESG, #DNA, #gene

Twisters across all sites have been gathering together to celebrate the holidays, end of year, and each other. Our South San Francisco, Wilsonville, and Carlsbad teams had a great time last week dressing up for a night out with snacks, drinks, friends and colleagues!

Wishing you a joyful holiday season and happy New Year! 🎁 🥂

	Sep '16	Sep '17	Sep '18	Sep '19	Sep '20	Sep '21	Sep '22	Sep '23
revenue	2.27M -	10.77M 374.53%	25.43M 136.16%	54.38M 113.89%	90.10M 65.67%	132.33M 46.87%	203.56M 53.83%	245.11M 20.41%
cost of revenue	9.42M -	24.02M 154.96%	32.19M 34.01%	47.43M 47.34%	61.41M 29.48%	80.62M 31.29%	119.33M 48.02%	155.38M 30.21%
gross profit	-7.15M -	-13.25M 85.30%	-6.76M 48.98%	6.96M 202.91%	28.69M 312.33%	51.71M 80.22%	84.23M 62.89%	89.73M 6.52%
selling and marketing expenses				1.30M -	1.20M 7.69%	2.50M 108.33%	2.40M 4%
general and administrative expenses				78.83M -	102.07M 29.48%	133.40M 30.70%	210.55M 57.83%
selling general and administrative expenses	18.27M -	26.06M 42.61%	43.45M 66.73%	80.13M 84.41%	103.27M 28.88%	135.90M 31.60%	212.95M 56.69%	189.74M 10.90%
research and development expenses	18.23M -	19.17M 5.15%	20.35M 6.15%	35.68M 75.37%	43.01M 20.52%	69.07M 60.61%	120.31M 74.18%	106.89M 11.15%
other expenses	73K -	-55K 175.34%	-121K 120%	-265K 119.01%	-182K 31.32%	-1.37M 652.75%	-1.09M 20.66%	-667K 38.64%
cost and expenses	45.92M -	69.25M 50.79%	95.99M 38.61%	163.24M 70.06%	207.68M 27.23%	285.59M 37.52%	452.59M 58.47%	452.01M 0.13%
operating expenses	36.50M -	45.23M 23.90%	63.80M 41.05%	115.81M 81.53%	146.27M 26.31%	204.97M 40.13%	333.26M 62.59%	296.63M 10.99%
interest expense	746K -	905K 21.31%	1.31M 45.08%	1.29M 1.45%	787K 39.18%	367K 53.37%	80K 78.20%	5K 93.75%
ebitda	-39.11M -	-53.10M 35.77%	-63.95M 20.43%	-106.08M 65.87%	-116.26M 9.60%	-154.19M 32.63%	-247.05M 60.22%	-193.21M 21.79%
operating income	-43.66M -	-58.48M 33.96%	-70.56M 20.65%	-108.85M 54.27%	-117.58M 8.02%	-153.26M 30.35%	-249.02M 62.48%	-217.16M 12.79%
depreciation and amortization	4.23M -	5.02M 18.73%	5.73M 14.06%	2.77M 51.69%	1.32M 52.40%	-935K 170.99%	1.98M 311.23%	23.95M 1,112.86%
total other income expenses net	73K -	-55K 175.34%	-121K 120%	1.47M 1,317.36%	-21.97M 1,591.51%	-768K 96.50%	20.75M 2,801.43%	-10.92M 152.65%
income before tax	-44.09M -	-59.03M 33.89%	-70.99M 20.27%	-107.38M 51.25%	-139.55M 29.96%	-154.03M 10.38%	-228.27M 48.20%	-203.47M 10.87%
income tax expense	819K -	280K 65.81%	242K 13.57%	292K 20.66%	382K 30.82%	-1.93M 605.24%	-10.41M 439.43%	1.15M 111.07%
net income	-44.09M -	-59.31M 34.53%	-71.24M 20.11%	-107.67M 51.14%	-139.93M 29.96%	-152.10M 8.69%	-217.86M 43.24%	-204.62M 6.08%
weighted average shs out	18.78M -	18.78M 0%	26.61M 41.69%	27.46M 3.20%	39.19M 42.71%	48.25M 23.12%	53.88M 11.68%	56.88M 5.57%
weighted average shs out dil	18.78M -	18.78M 0%	26.61M 41.69%	27.46M 3.20%	39.19M 42.71%	48.25M 23.12%	53.88M 11.68%	56.88M 5.57%
eps	-2.35 -	-3.16 34.47%	-2.68 15.19%	-3.92 46.27%	-3.57 8.93%	-3.15 11.76%	-4.04 28.25%	-3.60 10.89%
epsdiluted	-2.35 -	-3.16 34.47%	-2.68 15.19%	-3.92 46.27%	-3.57 8.93%	-3.15 11.76%	-4.04 28.25%	-3.60 10.89%

NASDAQ:TWST

Twist Bioscience

Last Close

57.51

26/07 20:00

Market Cap

2.97B

Beta: 1.17

Volume Today

666.23K

Avg: 1.36M

PE Ratio

−9.65

PFCF: −9.75

Preview